Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Clinical trial NCT01861301 · TERMINATED

Trial details

NCT number: NCT01861301
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelioid Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Stage II Pleural Mesothelioma Stage III Pleural Mesothelioma Stage IV Pleural Mesothelioma

Start date: 2013-01-01
Primary completion: 2015-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.